Ideation and assessment of a nitric oxide delivery system for spontaneously breathing subjects

There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit conn...

Full description

Saved in:
Bibliographic Details
Published inNitric oxide Vol. 104-105; pp. 29 - 35
Main Authors Gianni, Stefano, Morais, Caio C.A., Larson, Grant, Pinciroli, Riccardo, Carroll, Ryan, Yu, Binglan, Zapol, Warren M., Berra, Lorenzo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system. The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0–50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, −0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%. The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects. •We conceived and tested a NO delivery system for spontaneously breathing subjects.•A scavenger containing calcium hydroxide reduces the inspired NO2 concentration.•A reservoir bag reduces variations of NO concentration during breathing.•In five healthy subjects breathing 164.8±10.74 ppm of NO, inspired NO2 was 0.7±0.13 ppm.•In a healthy subject breathing 153 ppm of NO, the exhaled NO2 was 0.03 ppm.
AbstractList • We conceived and tested a NO delivery system for spontaneously breathing subjects. • A scavenger containing calcium hydroxide reduces the inspired NO 2 concentration. • A reservoir bag reduces variations of NO concentration during breathing. • In five healthy subjects breathing 164.8 ± 10.74 ppm of NO, inspired NO 2 was 0.7 ± 0.13 ppm. • In a healthy subject breathing 153 ppm of NO, the exhaled NO 2 was 0.03 ppm.
There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO ) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system. The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%. The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects.
There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described.BACKGROUNDThere is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described.We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system.METHODSWe developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system.The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%.RESULTSThe system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%.The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects.CONCLUSIONSThe system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects.
There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system. The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0–50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, −0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%. The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects. •We conceived and tested a NO delivery system for spontaneously breathing subjects.•A scavenger containing calcium hydroxide reduces the inspired NO2 concentration.•A reservoir bag reduces variations of NO concentration during breathing.•In five healthy subjects breathing 164.8±10.74 ppm of NO, inspired NO2 was 0.7±0.13 ppm.•In a healthy subject breathing 153 ppm of NO, the exhaled NO2 was 0.03 ppm.
Author Larson, Grant
Gianni, Stefano
Zapol, Warren M.
Berra, Lorenzo
Pinciroli, Riccardo
Morais, Caio C.A.
Carroll, Ryan
Yu, Binglan
Author_xml – sequence: 1
  givenname: Stefano
  surname: Gianni
  fullname: Gianni, Stefano
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 2
  givenname: Caio C.A.
  surname: Morais
  fullname: Morais, Caio C.A.
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 3
  givenname: Grant
  orcidid: 0000-0003-3308-1591
  surname: Larson
  fullname: Larson, Grant
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 4
  givenname: Riccardo
  orcidid: 0000-0003-2567-1591
  surname: Pinciroli
  fullname: Pinciroli, Riccardo
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 5
  givenname: Ryan
  orcidid: 0000-0002-7513-7023
  surname: Carroll
  fullname: Carroll, Ryan
  organization: Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA
– sequence: 6
  givenname: Binglan
  surname: Yu
  fullname: Yu, Binglan
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 7
  givenname: Warren M.
  surname: Zapol
  fullname: Zapol, Warren M.
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 8
  givenname: Lorenzo
  surname: Berra
  fullname: Berra, Lorenzo
  email: lberra@mgh.harvard.edu
  organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32835810$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1rGzEQFSWlSdz-gR6Kjr14I2m1ay2UQgn9CAR6aa8VWmmUyOxKrkY28b-vXCch7SGnGZj3wbx3Tk5iikDIW84aznh_sW5iSHeNYII1TDWMyRfkjDM1LFXP-cnjztpTco64ZhXRqv4VOW2FajvF2Rn5deXAlJAiNdFRgwiIM8RCk6eGxlBysDTdBQfUwRR2kPcU91hgpj5lipsUi4mQtjjt6Zir1m2INxS34xpswdfkpTcTwpv7uSA_v3z-cfltef3969Xlp-ullV1XlmJgQ-sdjMLDIHrhpTfA7eClktA6aZSxPePdaI1UClzPVp31nXG9XTk1-HZBPh51N9txBmfrB9lMepPDbPJeJxP0v5cYbvVN2umVlHwYhirw_l4gp99bwKLngBam6ficFrJdccFrgBX67qnXo8lDqBWgjgCbE2IGr20of0Ou1mHSnOlDf3qtD_3pQ3-aKX1oZ0HEf9QH9WdJH44kqAnvAmSNNkC04EKuJWiXwnP0P_8NuAU
CitedBy_id crossref_primary_10_1097_AOG_0000000000004847
crossref_primary_10_1016_j_niox_2023_05_007
crossref_primary_10_3390_biomedicines10071525
crossref_primary_10_3390_biomedicines10020369
crossref_primary_10_1016_j_ajem_2022_04_052
crossref_primary_10_1016_j_poly_2022_115822
crossref_primary_10_4187_respcare_09308
crossref_primary_10_1371_journal_pone_0258368
crossref_primary_10_3389_fcvm_2024_1374635
crossref_primary_10_1016_j_niox_2024_06_003
crossref_primary_10_1016_j_niox_2021_08_003
crossref_primary_10_1097_CCE_0000000000000277
crossref_primary_10_1007_s11172_024_4454_9
crossref_primary_10_1016_j_virusres_2020_198202
Cites_doi 10.1164/rccm.202005-1906ED
10.1213/ANE.0b013e3181f46da8
10.1093/bja/74.1.107-a
10.1155/2020/1536714
10.1016/j.transproceed.2008.08.124
10.1097/00000542-200611000-00008
10.1016/j.jcf.2013.01.008
10.1016/j.virol.2009.09.007
10.1136/bmjopen-2018-026848
10.1136/ewjm.175.3.193
10.1136/thoraxjnl-2015-208209
10.1128/JVI.79.3.1966-1969.2005
ContentType Journal Article
Copyright 2020 Elsevier Inc.
Copyright © 2020 Elsevier Inc. All rights reserved.
2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc.
Copyright_xml – notice: 2020 Elsevier Inc.
– notice: Copyright © 2020 Elsevier Inc. All rights reserved.
– notice: 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1016/j.niox.2020.08.004
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1089-8611
EndPage 35
ExternalDocumentID PMC7441999
32835810
10_1016_j_niox_2020_08_004
S1089860320301828
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R21 HL130956
– fundername: NHLBI NIH HHS
  grantid: U54 HL119145
– fundername: NHLBI NIH HHS
  grantid: K23 HL128882
GroupedDBID ---
--K
--M
-~X
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
5RE
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
ABGSF
ABMAC
ABUDA
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DM4
EBS
EFBJH
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
IHE
J1W
KOM
LG5
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSH
SSU
SSZ
T5K
WH7
ZU3
~G-
.55
.GJ
29N
3O-
53G
AAQXK
AAYWO
AAYXX
ABFNM
ABWVN
ABXDB
ACRPL
ACVFH
ADCNI
ADFGL
ADMUD
ADNMO
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRDE
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
APXCP
ASPBG
AVWKF
AZFZN
CAG
CITATION
COF
EJD
FGOYB
HZ~
H~9
R2-
RIG
SEW
X7M
XPP
ZGI
NPM
7X8
5PM
EFKBS
ID FETCH-LOGICAL-c455t-29093fdeb2fe9262f4fae1c9f484e3d4a8ac6015bca488ed6075cf5ad6c7d89f3
IEDL.DBID .~1
ISSN 1089-8603
1089-8611
IngestDate Thu Aug 21 13:30:25 EDT 2025
Thu Jul 10 20:05:42 EDT 2025
Thu Apr 03 07:08:28 EDT 2025
Tue Jul 01 03:23:03 EDT 2025
Thu Apr 24 22:55:46 EDT 2025
Sun Apr 06 06:53:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Delivery system
Nitrogen dioxide
Nitric oxide
Language English
License Copyright © 2020 Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c455t-29093fdeb2fe9262f4fae1c9f484e3d4a8ac6015bca488ed6075cf5ad6c7d89f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-7513-7023
0000-0003-2567-1591
0000-0003-3308-1591
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7441999
PMID 32835810
PQID 2437121043
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7441999
proquest_miscellaneous_2437121043
pubmed_primary_32835810
crossref_citationtrail_10_1016_j_niox_2020_08_004
crossref_primary_10_1016_j_niox_2020_08_004
elsevier_sciencedirect_doi_10_1016_j_niox_2020_08_004
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Nitric oxide
PublicationTitleAlternate Nitric Oxide
PublicationYear 2020
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Feiner, Bickler (bib12) 2010; 111
Akerström, Gunalan, Keng, Tan, Mirazimi (bib3) 2009; 395
Pickett, Mahmood, Latimer, Powroznyk, Ghosh, Oduro (bib10) 1995; 74
Miller, Hergott, Rohan, Arsenault-Mehta, Döring, Mehta (bib15) 2013; 12
Safaee Fakhr, Wiegand, Pinciroli, Gianni (bib18) 2020
Marrazzo, Spina, Zadek (bib8) 2019; 9
(bib14) 2020
Alvarez, Berra, Gladwin (bib19) 2020; 202(1)
Barker, Curry, Redford, Morgan (bib13) 2006; 105
Bartley (bib16) 2020
McMullin, Chittock, Roscoe, Garcha, Wang, Miller (bib2) 2005; 50
Davidson, Banham, Elliott (bib11) 2016; 71
Berra, Lei, Su (bib6) 2020
Moreno, Mir, Vicente (bib17) 2008; 40
Lei C, Su B, Dong H, et al. Title: Protocol of a Randomized Controlled Trial Testing Inhaled Nitric Oxide in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 (SARS-CoV-2).:16..
Rehman (bib9) 2001; 175
Akerström, Mousavi-Jazi, Klingström, Leijon, Lundkvist, Mirazimi (bib4) 2005; 79
Gianni S, Fakhr BS, Morais CCA, et al. Nitric Oxide Gas Inhalation to Prevent COVID-2019 in Healthcare Providers. :14.
bib1
Alvarez (10.1016/j.niox.2020.08.004_bib19) 2020; 202(1)
Akerström (10.1016/j.niox.2020.08.004_bib3) 2009; 395
Berra (10.1016/j.niox.2020.08.004_bib6) 2020
Marrazzo (10.1016/j.niox.2020.08.004_bib8) 2019; 9
McMullin (10.1016/j.niox.2020.08.004_bib2) 2005; 50
Moreno (10.1016/j.niox.2020.08.004_bib17) 2008; 40
Akerström (10.1016/j.niox.2020.08.004_bib4) 2005; 79
Davidson (10.1016/j.niox.2020.08.004_bib11) 2016; 71
Miller (10.1016/j.niox.2020.08.004_bib15) 2013; 12
Feiner (10.1016/j.niox.2020.08.004_bib12) 2010; 111
10.1016/j.niox.2020.08.004_bib5
Safaee Fakhr (10.1016/j.niox.2020.08.004_bib18) 2020
Rehman (10.1016/j.niox.2020.08.004_bib9) 2001; 175
Bartley (10.1016/j.niox.2020.08.004_bib16) 2020
Pickett (10.1016/j.niox.2020.08.004_bib10) 1995; 74
10.1016/j.niox.2020.08.004_bib7
Barker (10.1016/j.niox.2020.08.004_bib13) 2006; 105
References_xml – volume: 50
  start-page: 6
  year: 2005
  ident: bib2
  article-title: The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit
  publication-title: Respir. Care
– start-page: 136
  year: 2020
  ident: bib18
  article-title: High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)
  publication-title: Obstet. Gynecol.
– year: 2020
  ident: bib14
  article-title: 1988 OSHA PEL project - nitrogen dioxide | NIOSH | CDC [internet]
– year: 2020
  ident: bib16
  article-title: High-dose inhaled nitric oxide as adjunct therapy in cystic fibrosis targeting Burkholderia multivorans
  publication-title: Case Reports in Pediatrics
– volume: 105
  start-page: 892
  year: 2006
  end-page: 897
  ident: bib13
  article-title: Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study
  publication-title: Anesthesiology
– volume: 79
  start-page: 1966
  year: 2005
  end-page: 1969
  ident: bib4
  article-title: Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
  publication-title: J. Virol.
– year: 2020
  ident: bib6
  article-title: Protocol for a Randomized Controlled Trial Testing Inhaled Nitric Oxide Therapy in Spontaneously Breathing Patients with COVID-19 [Internet]. Intensive Care and Critical Care Medicine
– volume: 71
  year: 2016
  ident: bib11
  article-title: BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults
  publication-title: Thorax
– volume: 40
  start-page: 3082
  year: 2008
  end-page: 3084
  ident: bib17
  article-title: Analysis of interleukin-6 and interleukin-8 in lung transplantation: correlation with nitric oxide administration
  publication-title: Transplant. Proc.
– volume: 9
  year: 2019
  ident: bib8
  article-title: Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas
  publication-title: BMJ Open
– volume: 202(1)
  start-page: 16
  year: 2020
  end-page: 20
  ident: bib19
  article-title: Home NO therapy for COVID-19
  publication-title: Am. J. Respir. Crit. Care Med.
– reference: Lei C, Su B, Dong H, et al. Title: Protocol of a Randomized Controlled Trial Testing Inhaled Nitric Oxide in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 (SARS-CoV-2).:16..
– volume: 175
  start-page: 193
  year: 2001
  end-page: 196
  ident: bib9
  publication-title: Methemoglobinemia. West J Med
– volume: 12
  start-page: 817
  year: 2013
  end-page: 820
  ident: bib15
  article-title: Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia
  publication-title: J. Cyst. Fibros.
– ident: bib1
  article-title: 20845_INOmax_Approv.pdf
– volume: 111
  start-page: 1160
  year: 2010
  end-page: 1167
  ident: bib12
  article-title: Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia
  publication-title: Anesth. Analg.
– volume: 395
  start-page: 1
  year: 2009
  end-page: 9
  ident: bib3
  article-title: Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected
  publication-title: Virology
– reference: Gianni S, Fakhr BS, Morais CCA, et al. Nitric Oxide Gas Inhalation to Prevent COVID-2019 in Healthcare Providers. :14.
– volume: 74
  start-page: 107
  year: 1995
  end-page: 108
  ident: bib10
  article-title: Effective absorption of nitrogen dioxide with soda lime
  publication-title: Br. J. Anaesth.
– volume: 202(1)
  start-page: 16
  year: 2020
  ident: 10.1016/j.niox.2020.08.004_bib19
  article-title: Home NO therapy for COVID-19
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.202005-1906ED
– volume: 111
  start-page: 1160
  issue: 5
  year: 2010
  ident: 10.1016/j.niox.2020.08.004_bib12
  article-title: Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia
  publication-title: Anesth. Analg.
  doi: 10.1213/ANE.0b013e3181f46da8
– volume: 74
  start-page: 107
  issue: 1
  year: 1995
  ident: 10.1016/j.niox.2020.08.004_bib10
  article-title: Effective absorption of nitrogen dioxide with soda lime
  publication-title: Br. J. Anaesth.
  doi: 10.1093/bja/74.1.107-a
– ident: 10.1016/j.niox.2020.08.004_bib5
– year: 2020
  ident: 10.1016/j.niox.2020.08.004_bib16
  article-title: High-dose inhaled nitric oxide as adjunct therapy in cystic fibrosis targeting Burkholderia multivorans
  publication-title: Case Reports in Pediatrics
  doi: 10.1155/2020/1536714
– year: 2020
  ident: 10.1016/j.niox.2020.08.004_bib6
– volume: 40
  start-page: 3082
  issue: 9
  year: 2008
  ident: 10.1016/j.niox.2020.08.004_bib17
  article-title: Analysis of interleukin-6 and interleukin-8 in lung transplantation: correlation with nitric oxide administration
  publication-title: Transplant. Proc.
  doi: 10.1016/j.transproceed.2008.08.124
– ident: 10.1016/j.niox.2020.08.004_bib7
– volume: 50
  start-page: 6
  issue: 11
  year: 2005
  ident: 10.1016/j.niox.2020.08.004_bib2
  article-title: The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit
  publication-title: Respir. Care
– volume: 105
  start-page: 892
  issue: 5
  year: 2006
  ident: 10.1016/j.niox.2020.08.004_bib13
  article-title: Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study
  publication-title: Anesthesiology
  doi: 10.1097/00000542-200611000-00008
– volume: 12
  start-page: 817
  issue: 6
  year: 2013
  ident: 10.1016/j.niox.2020.08.004_bib15
  article-title: Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia
  publication-title: J. Cyst. Fibros.
  doi: 10.1016/j.jcf.2013.01.008
– volume: 395
  start-page: 1
  issue: 1
  year: 2009
  ident: 10.1016/j.niox.2020.08.004_bib3
  article-title: Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected
  publication-title: Virology
  doi: 10.1016/j.virol.2009.09.007
– volume: 9
  issue: 7
  year: 2019
  ident: 10.1016/j.niox.2020.08.004_bib8
  article-title: Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-026848
– volume: 175
  start-page: 193
  issue: 3
  year: 2001
  ident: 10.1016/j.niox.2020.08.004_bib9
  publication-title: Methemoglobinemia. West J Med
  doi: 10.1136/ewjm.175.3.193
– volume: 71
  issue: Suppl 2
  year: 2016
  ident: 10.1016/j.niox.2020.08.004_bib11
  article-title: BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2015-208209
– volume: 79
  start-page: 1966
  issue: 3
  year: 2005
  ident: 10.1016/j.niox.2020.08.004_bib4
  article-title: Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.3.1966-1969.2005
– start-page: 136
  year: 2020
  ident: 10.1016/j.niox.2020.08.004_bib18
  article-title: High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)
  publication-title: Obstet. Gynecol.
SSID ssj0004386
Score 2.3705177
Snippet There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously...
• We conceived and tested a NO delivery system for spontaneously breathing subjects. • A scavenger containing calcium hydroxide reduces the inspired NO 2...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 29
SubjectTerms Analytical Methods
Delivery system
Nitric oxide
Nitrogen dioxide
Title Ideation and assessment of a nitric oxide delivery system for spontaneously breathing subjects
URI https://dx.doi.org/10.1016/j.niox.2020.08.004
https://www.ncbi.nlm.nih.gov/pubmed/32835810
https://www.proquest.com/docview/2437121043
https://pubmed.ncbi.nlm.nih.gov/PMC7441999
Volume 104-105
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqogouCFoey6NyJcQFpZusJw8flxXV9qEKAZV6quX4IYKWpGJ3pe6F385MnCwsVD1wymssWZ6J_Y098w1jbxIwsrDCRklWQgTCjCJpSxs5oBNC8CNjWrbP82x6ASeX6eUWm_S5MBRW2c39YU5vZ-vuzbAbzeF1VQ0_J3Ehi4wKgKORouNAGeyQk5Uf_vwd5gGirfZIwhFJd4kzIcarrpob9BFHcUvj2RVru2Vx-hd8_h1D-ceidPSIPezQJB-HDj9mW67eZXvjGj3p7yv-lrfxne3G-S7bed_f3Z_0Vd722NWxDaiR69pyvebp5I3nmuP_jvMkb24q67h1MwriWPHA_swR7nIKsEV46ZrlfLbiJSFQ2tLi82VJGzzzJ-zi6MOXyTTqai5EBtJ0EY1kLIW36G97R1SCHrx2iZEeCnDCgi60QR8uLYkNvXA2Q8hhfKptZnJbSC-esu26qd1zxhEoydilibalAHSzdCYdIBrIROwyl8OAJf1gK9MRklNdjJnqI8--KVKQIgUpKpYZY5t36zbXgY7jTum016HaMCqF68Wd7Q56hStUBx2hhJFURN9IlGsgBuxZMIB1PwRR1xVJPGD5hmmsBYjJe_NLXX1tGb1zBKWI1F_8Z39fsgf0FFIkX7HtxY-le41YaVHutz_DPrs3nnw6-0jX49Pp-S8cdRes
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTmh7QbDxUT6NhHhBUZPaSZPHUjG1bPSFTdoTluMPLagk09pK63_PXewUCmgPvEWxT7J8Z_t39t3vAN4lQhe54SZKslJEguthVJjSRFbQC6FwQ61bts95Nr0Qny_Tyz2YdLkwFFYZ9n6_p7e7dfgzCLM5uK6qwdckzos8owLgaKToONyDfWKnSnuwP56dTue_0iN5W_CR-kckEHJnfJhXXTW36CYO45bJM9Rr-8f59Df-_DOM8rdz6eQhPAiAko39mB_Bnq2P4HhcozP9Y8PeszbEs707P4L7H7uvg0lX6O0Yvs2MB45M1YapLVUnaxxTDJc8bpWsua2MZcYuKI5jwzwBNEPEyyjGFhGmbdbLxYaVBELpVost1yXd8Swfw8XJp_PJNAplFyIt0nQVDYu44M6gy-0ssQk64ZRNdOFELiw3QuVKoxuXlkSInluTIerQLlUm0yOTF44_gV7d1PYZMMRKRWzTRJmSC_S0VFZYgYAg47HN7Ej0IekmW-rASU6lMRayCz77LklBkhQkqV5mjDIftjLXnpHjzt5pp0O5Y1cSj4w75d52CpeoDnpF8TMpicGRWNcE78NTbwDbcXBir8uTuA-jHdPYdiAy792WurpqSb1HiEsRrD__z_G-gYPp-ZczeTabn76AQ2rxGZMvobe6WdtXCJ1W5euwNH4C2GQYyA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ideation+and+assessment+of+a+nitric+oxide+delivery+system+for+spontaneously+breathing+subjects&rft.jtitle=Nitric+oxide&rft.au=Gianni%2C+Stefano&rft.au=Morais%2C+Caio+C+A&rft.au=Larson%2C+Grant&rft.au=Pinciroli%2C+Riccardo&rft.date=2020-11-01&rft.issn=1089-8611&rft.eissn=1089-8611&rft.volume=104-105&rft.spage=29&rft_id=info:doi/10.1016%2Fj.niox.2020.08.004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1089-8603&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1089-8603&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1089-8603&client=summon